Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.63 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.63 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.63 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.63 |
| ▸ | USP8 | P40818 | 6/20 | 0.61 |
| ▸ | TERT | O14746 | 5/20 | 0.60 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.52 |
| ▸ | TUBB | P07437 | 1/20 | 0.52 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.52 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.52 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.52 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.52 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.52 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.52 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.52 |
| ▸ | TUBA3E | Q6PEY2 | 1/20 | 0.52 |
| ▸ | TUBA1A | Q71U36 | 1/20 | 0.52 |
| ▸ | TUBA1C | Q9BQE3 | 1/20 | 0.52 |
| ▸ | TUBB6 | Q9BUF5 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22772263 | 0.89 | USP8 (0.51) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL21647176 | 0.88 | USP8 (0.72) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL23473437 | 0.86 | USP8 (0.58) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL6612282 | 0.81 | TUBB4A (0.76) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL21647169 | 0.80 | CYP1A2 (0.73) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL16704751 | 0.80 | CYP1A1 (0.76) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL27381836 | 0.80 | CYP1A2 (0.73) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL21668254 | 0.80 | USP8 (0.51) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL4649487 | 0.80 | CYP3A4 (0.76) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 | |
| SCHEMBL29612043 | 0.80 | TERT (0.77) | CYP3A4CYP2C19CYP1A2NCOA1NCOA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110790739-B | Compounds for treating neurological diseases and uses thereof | 陕西麦科奥特科技有限公司 | 2021-10-01 | — | — | CN | disclosed |
| EP-3831821-A1 | COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF | Shaanxi Micot Technology Limited Company (CN) | 2021-06-09 | — | — | EP | disclosed |
| EP-3831821-A1 | COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF | Shaanxi Micot Technology Limited Company (CN) | 2021-06-09 | — | — | EP | disclosed |
| US-20200390755-A1 | COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF | SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) | 2020-12-17 | — | — | US | disclosed |
| US-20200390755-A1 | COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF | SHAANXI MICOT TECHNOLOGY CO., LTD. (CN) | 2020-12-17 | — | — | US | disclosed |
| CN-110790739-A | Compounds for treating neurological diseases and uses thereof | 陕西麦科奥特科技有限公司 | 2020-02-14 | — | — | CN | disclosed |
| WO-2020024977-A1 | COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF | 陕西麦科奥特科技有限公司 | 2020-02-06 | — | — | WO | disclosed |
| WO-2020024977-A1 | COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF | 陕西麦科奥特科技有限公司 | 2020-02-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200390755-A1 | COMPOUND FOR TREATING NERVOUS SYSTEM DISEASES AND USE THEREOF | MAPT, PYGB, SLC6A2 | CYP3A4 184/4885CYP2C19 123/4885CYP1A2 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.